ArticleHepatology (Baltimore, Md.)2026

Anti-angiogenic therapy combined with immune checkpoint blockade mediates CCR7 + CD8 + T-cell entry into HCC through high endothelial venules.

Lu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.